Why Skin Deposition is the Next Frontier in Skincare Globally
Why skin deposition is the next frontier. Explore how the NanoBase™ architecture improves active retention and stability compared to traditional SLNs and NLCs.
Why skin deposition is the next frontier. Explore how the NanoBase™ architecture improves active retention and stability compared to traditional SLNs and NLCs.
You bring the vision, we bring the nanoscience. Your formula is engineered on NanoBase™, our tri-domain nano-delivery architecture, and the complete blueprint is yours, free, before you commit to anything.
When you start a skincare brand, the first real decision isn't your packaging or your name. It's what your formulas are actually built on, and there are only two main options: build for surface-level performance like it's 1949, or build for modern performance. Ingredient selection doesn't really matter if they're not being delivered.
NanoBase™ is our nano-delivery architecture, the modern replacement for the 1949 HLB emulsions most of the industry still uses. Instead of large droplets that mostly sit on the skin's surface, it restructures your formula into engineered nano-scale carriers (around 185 nm) across three domains: nanoliposomal, nanoemulsion, and nanomicellar. The result is a formula built to actually deliver the actives you're paying for, with stability and copy-resistance built in.
Read the published paper DOI: 10.5281/zenodo.18616576 →Compete with the 90% of the industry still on HLB.
Outperform them.
Legacy HLB formulas rely on a single delivery interface, so every active has to share one compromise. NanoBase™ runs three coordinated nano-domains in parallel inside one lipid matrix, each suited to a different kind of active and a different job on the skin. Microbiome condition, skin type, and external environment are HLB questions and problems that don’t apply to formulas built on NanoBase™.
The bottom line: you can compete with the 90% of the industry still building on HLB, or you can outperform them.
Skin type, microbiome state, climate: these are the variables that make legacy formulas behave differently on different people. A static HLB macro-emulsion can’t account for them, so results swing. NanoBase™ is self-adaptive in real time: its coordinated lipid domains respond to the skin’s own conditions as they’re applied, so the delivery profile holds across skin types, microbiome states, and environments.
Phospholipid bilayers that carry water- and oil-loving actives together.
Oil nanodroplets that keep lipophilic actives kinetically stable and evenly dispersed.
Surfactant aggregates for surface delivery and solubilization.
Fully modular means fully portable. Once your formula is built on NanoBase™, it is not tied to us or to any single facility. You can have it produced by the contract manufacturer of your choice, from the lab notes and scale-up SOP we hand you. No special or proprietary manufacturer is required to produce your formula on our NanoBase™ technology, so you are never locked in. You own the formula, and you make it wherever fits your brand.
This is an actual NanoBase™ AI Chemist executive summary for a trending brightening and barrier serum (a vitamin C complex, niacinamide, and hyaluronic acid). Every delivery figure is derived per ingredient from published Franz diffusion, tape-stripping, and confocal Raman studies, not marketing math.
Example generated by the NanoBase™ AI Chemist for a sample serum. Delivery percentages are derived per ingredient from published nano-carrier vs conventional macro-emulsion studies (full citations in the executive summary). Biomarker figures in the full report are model projections, not clinical results. Particle size is an engineered design target, confirmed at finished-formulation QC.
Generate your own, free →We benchmarked 100 of the most-used cosmetic actives, NanoBase™ versus a conventional HLB macroemulsion. Every figure is anchored to peer-reviewed literature, linked on each row. Search your active or filter by category.
Class-level delivery benchmark drawn from peer-reviewed nano-carrier vs macroemulsion literature, not a finished-product efficacy claim. Finished-formulation clinical testing is required before any consumer efficacy claim. Each row links to its primary source.
Technology, process, pricing, IP, and support, everything you’d want to know before you start. We’ll email you a personalized summary at the end.
Book a free discovery call and share your idea, target market, and goals. No idea is too early, even “I want to make a really good vitamin C serum” is enough to start.
Submit your idea to the NanoBase™ AI Chemist yourself, or request we do it during your Zoom discovery call and we’ll run it for you. Either way you get a complete blueprint: full ingredient percentages and a clear executive summary, at no cost. The NanoBase™ AI Chemist is the first of its kind built by an actual lab, not a data or tech company, on a knowledge base our founder built in-house.
No pressure, ever. When you’re ready to move forward, we put a clear agreement in place. A one-off formula averages around $7,500 depending on complexity, with reduced per-formula pricing when you build a line of multiple formulas. The finished formula is always yours to own.
Review our mutual NDA →
We order your ingredients and schedule your bench time (typically within ~2 weeks of arrival). We never share ingredients between clients, every client gets dedicated lab storage.
Bench development with DLS validation and an Accelerated Physicochemical Robustness Test (thermal cycling + centrifugation). Your first sample ships while robustness data accrues, so you can react quickly. We refine until it’s right.
Once your agreement is complete, you receive our lab notes and a scale-up SOP for manufacturing, plus optional fractional-COO support if you want a guide for what’s next.
Most labs hand you a formula and wish you luck. Launching a brand means a hundred decisions, here’s where we help.
We help you find and manage the right production partner for your product type, volume, and budget, and encourage you to inspect the facility yourself.
Guidance through the regulatory and labeling requirements that come with putting a product on the market.
Pointers on the coverage and brand protection most founders don’t know they need until late.
Help choosing packaging that fits your formula, your brand, and your fulfillment reality.
Want something exclusive? We can engineer a signature nano-delivery architecture unique to your brand.
Optional hands-on operational support if you’d like a partner in the build, not just a formula.
Compete with 90% of the industry, or outperform it.
Book a free discovery call and we’ll build your no-cost formulation blueprint. No commitment, just see what’s possible.
Book my free discovery call →We’ll formulate your product on paper before you sign a single contract. You see exactly what you’d be building, and why it’s different.
Two ways to start, no commitment.
Pensive Beauty® and NanoBase™ products are cosmetics intended to affect the appearance and feel of the skin; they are not intended to diagnose, treat, cure, or prevent any disease. Delivery and performance figures, including the active-delivery benchmark and the example executive summary, are class-level comparisons of nano-carrier versus conventional HLB macroemulsion delivery drawn from the peer-reviewed literature cited in our white papers, and are not finished-product efficacy claims. Self-adaptive and responsiveness statements describe the design intent of the architecture and established lipid-carrier science, not a guaranteed outcome. Particle size (~185 nm) is an engineered design target confirmed on the finished formulation at QC, not a per-formula measurement. Biomarker projections in any report are model estimates, not clinical results. The 90% figure is an internal industry estimate. Finished-formulation clinical testing is required before any consumer-facing efficacy claim is made. The NanoBase™ AI Chemist provides AI-generated guidance that can contain errors; validate critical outputs on the bench. This page is provided for general education and is not a substitute for professional regulatory or legal review.